DaShenLin Pharmaceutical Group Co Ltd banner

Wall St Price Targets

Price Forecast
Based on 6 analysts

+28% Upside
from ¥20.72 today

DaShenLin Pharmaceutical Group Co Ltd (603233)’s 12-month stock price forecast through November 2027 has a consensus target of ¥26.52, implying 28% upside. The forecast is based on price targets from 6 Wall Street analysts.

Analyst Rating
No ratings yet

No rating

We don't have analyst ratings for DaShenLin Pharmaceutical Group Co Ltd yet.

DaShenLin Pharmaceutical Group Co Ltd Competitors:
Price Targets

Financial Estimates

Past growth per year

Average annual growth cannot be calculated for these periods.

Explore analyst estimates, growth and forecast ranges.

Reported Lowest–highest estimate

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is DaShenLin Pharmaceutical Group Co Ltd's stock price target?
Price Target
26.52 CNY

According to Wall Street analysts, the average 1-year price target for DaShenLin Pharmaceutical Group Co Ltd is 26.52 CNY with a low forecast of 15.15 CNY and a high forecast of 27.83 CNY.

What is the Revenue forecast for DaShenLin Pharmaceutical Group Co Ltd?
Projected CAGR
9%

Over the last 10 years, the compound annual growth rate for Revenue has been 18%. The projected CAGR for the next 3 years is 9%.

What is the Gross Profit forecast for DaShenLin Pharmaceutical Group Co Ltd?
Projected CAGR
9%

Over the last 10 years, the compound annual growth rate for Gross Profit has been 16%. The projected CAGR for the next 3 years is 9%.

What is the Operating Income forecast for DaShenLin Pharmaceutical Group Co Ltd?
Projected CAGR
17%

Over the last 10 years, the compound annual growth rate for Operating Income has been 13%. The projected CAGR for the next 3 years is 17%.

What is the Pre-Tax Income forecast for DaShenLin Pharmaceutical Group Co Ltd?
Projected CAGR
16%

Over the last 10 years, the compound annual growth rate for Pre-Tax Income has been 13%. The projected CAGR for the next 3 years is 16%.

What is the Net Income forecast for DaShenLin Pharmaceutical Group Co Ltd?
Projected CAGR
16%

Over the last 10 years, the compound annual growth rate for Net Income has been 12%. The projected CAGR for the next 3 years is 16%.

Back to Top